Bacterial Cybergenetics | AMR | Nemesis Bioscience

Latest News

Keep up to date with the latest news and developments from Nemisis Bioscience.

3 NEMESIS BIOSCIENCE ANNOUNCES RESEARCH COLLABORATION WITH SHIONOGI Nemesis Bioscience Ltd announced today that it had reached an agreement on terms for a two-year research collaboration with Shionogi & Co. Ltd. to further develop Nemesis Transmid Technology© for the treatment and/or prevention of hard-to-treat respiratory infections caused by Pseudomonas aeruginosa. The collaboration will leverage the innovative science and technology platforms of both parties… 06.07.2020
0 NEMESIS BIOSCIENCE WINS INNOVATE UK SBRI FUNDING AWARD Nemesis Bioscience has been successful in winning a £414, 000 award granted by the UK’s innovation agency, Innovate UK. The Small Business Research Initiative (SBRI) competition was open to organisations of any type and size who had an innovative way to combat one of the most pressing threats to global health – antimicrobial resistance (AMR)… 27.03.2019
1 NEMESIS BIOSCIENCE EXPANDS DEVELOPMENT FACILITY IN ABERYSTWYTH Nemesis Bioscience today announced the expansion of its presence in Aberystwyth by opening a new pre-clinical development facility at the University. Having become members at the Aberystwyth Innovation and Enterprise Campus in August 2018, the company grew its operations during the following months by recruiting new full-time staff and moving into laboratory space at the… 12.02.2019